Certain FDAMA Provisions Underutilized By Device Firms, Hill Aide Says
This article was originally published in The Gray Sheet
Executive Summary
Manufacturers should be more aggressive in pressing for their rights under the FDA Modernization Act, Senate Labor and Human Resources Health Policy Advisor Jay Hawkins told the Regulatory Affairs Professionals Society Oct. 28 in Washington, D.C.
You may also be interested in...
CDRH FY 2000 Performance Goals Focus On Sponsor Meetings, Review Times
FDA's Center for Devices and Radiological Health is pledging to hold 65% of premarket approval application "determination" and investigational device exemption "agreement" meetings within 30 days of a sponsor's request in fiscal 2000, FDA officials report.
CDRH FY 2000 Performance Goals Focus On Sponsor Meetings, Review Times
FDA's Center for Devices and Radiological Health is pledging to hold 65% of premarket approval application "determination" and investigational device exemption "agreement" meetings within 30 days of a sponsor's request in fiscal 2000, FDA officials report.
FDA Committed To Third-Party Review, Henney Tells Senate HELP Committee
FDA Commissioner Jane Henney is "puzzled" about the low utilization rate within the device industry of the agency's "Accredited Persons" third-party premarket review program, she said at an Oct. 21 Senate Health, Education, Labor and Pensions Committee hearing.